Singapore - English - HSA (Health Sciences Authority)

canon medical systems asia pte., ltd. - radiology / imaging - intended for multidirectional observation of the flow of contrast medium injected into the blood vessels of a patient. cardiac system is designed for selective cardiac angiography (with catheterization). this system is intended for use in interventional procedures for cardiac vessels, such as pci, and also for use in ep (electrophysiological) studies. vascular system is designed for selective angiography (with catheterization) of the head, abdomen, and lower extremities. this system is intended for use in interventional procedures, such as embolization, for blood vessels in the head, abdomen, and lower extremities.

Singapore - English - HSA (Health Sciences Authority)

canon medical systems asia pte., ltd. - radiology / imaging - infx-8000h systems are diagnostic x-ray systems designed for multidirectional observation of the flow of contrast medium injected into the blood vessels of a patient.

Singapore - English - HSA (Health Sciences Authority)

demant singapore pte ltd - ear, nose & throat - the digisonic® sp cochlear implant is designed to rehabilitate patients who have 2nd degree severe to total bilateral hearing loss with a speech intelligibility level of less than 50% at 60 db hl in open-set format with the use of a hearing aid (professional medical opinion required). digisonic® sp binaural is not indicated in still growing children under 16 years old.

Israel - English - Ministry of Health

a.l. medi-market ltd. - nitroprusside sodium anhydrous - powder for solution for infusion - nitroprusside sodium anhydrous 52.75 mg - nitroprusside - nipruss is indicated in:• hypertensive crisis• controlled intraoperative hypotension nipruss is not suitable for permanent therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet - excipient ingredients: lactose monohydrate; hyprolose; microcrystalline cellulose; stearic acid; magnesium stearate; titanium dioxide; hypromellose; purified talc - olmesartan medoxomil is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; hyprolose; stearic acid; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc - olmesartan medoxomil is indicated for the treatment of hypertension.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - rosuvastatin calcium -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - rosuvastatin calcium -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 20 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: hypromellose; purified water; hyprolose; lactose monohydrate; magnesium stearate; microcrystalline cellulose; titanium dioxide; iron oxide yellow; macrogol 4000 - indicated for the treatment of hypertension.,treatment should not be initiated with this fixed dose combination.